LON:BOYBodycote Share Price, Forecast & News

Bodycote's stock was trading at GBX 641 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BOY shares have decreased by 12.6% and is now trading at GBX 560.
View which stocks have been most impacted by Coronavirus.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bodycote in the last year. There are currently 3 sell ratings, 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bodycote.

Bodycote PLC (LON:BOY) announced its quarterly earnings results on Tuesday, March, 6th. The company reported $49.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $47.20 by $2.00. The business earned $690.20 million during the quarter.
View Bodycote's earnings history.

Bodycote announced a dividend on Thursday, July 23rd. Investors of record on Thursday, August 27th will be given a dividend of GBX 13.30 per share on Friday, September 25th. This represents a yield of 2.17%. The ex-dividend date is Thursday, August 27th. The official announcement can be accessed at this link.
View Bodycote's dividend history.

13 brokerages have issued 1-year target prices for Bodycote's stock. Their forecasts range from GBX 530 to GBX 1,060. On average, they anticipate Bodycote's share price to reach GBX 685 in the next year. This suggests a possible upside of 22.3% from the stock's current price.
View analysts' price targets for Bodycote.

News stories about BOY stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Bodycote earned a coverage optimism score of 1.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future.
View the latest news about Bodycote.

Some companies that are related to Bodycote include Rheinmetall (RHM), IMI (IMI), Rotork (ROR), Krones (KRN), Duerr (DUE), ATS Automation Tooling Systems (ATA), Pfeiffer Vacuum Technology (PFV), Kuka (KU2), Jungheinrich (JUN3), Stabilus (STM), Savaria (SIS), Morgan Advanced Materials (MGAM), Deutz (DEZ), PyroGenesis Canada (PYR) and General Electric (GEC).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bodycote investors own include BTG (BTG), Indivior (INDV), Kenmare Resources (KMR), Diageo (DEO), AstraZeneca (AZN), Legal & General Group (LGEN), Lloyds Banking Group (LLOY), Meggitt (MGGT), Marks and Spencer Group (MKS) and NVIDIA (NVDA).

Bodycote trades on the London Stock Exchange (LON) under the ticker symbol "BOY."

Shares of BOY and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of BOY stock can currently be purchased for approximately GBX 560.

Bodycote has a market capitalization of £1.07 billion and generates £659.90 million in revenue each year. Bodycote employs 5,647 workers across the globe.

The official website for Bodycote is www.bodycote.com.

Bodycote's mailing address is Springwood Court, Springwood Close, MACCLESFIELD, SK10 2XF, United Kingdom. The company can be reached via phone at +44-1625-505300.